Hello

Aquestive sheds a third after receiving FDA response for Libervant application

Aquestive Therapeutics drops nearly 30% premarket after receiving FDA notification regarding the rev
Aquestive sheds a third after receiving FDA response for Libervant application

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

举报

评论2

  • 推荐
  • 最新
empty
暂无评论